These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3873405)

  • 1. Secretion of idiotypic IgM by the mouse B-cell leukaemia (BCL1) occurs spontaneously in vitro and in vivo.
    Tutt AL; Stevenson FK; Slavin S; Stevenson GT
    Immunology; 1985 May; 55(1):59-63. PubMed ID: 3873405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ; Tutt AL; Stevenson FK
    J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin produced by guinea-pig leukaemic B lymphocytes: its source and use as a monitor of tumour load.
    Stevenson FK; Morris D; Stevenson GT
    Immunology; 1980 Oct; 41(2):313-21. PubMed ID: 6969218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiotypic vaccination as a treatment for a B cell lymphoma.
    George AJ; Folkard SG; Hamblin TJ; Stevenson FK
    J Immunol; 1988 Sep; 141(6):2168-74. PubMed ID: 3049800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of immunoglobulin by neoplastic B lymphocytes from lymph nodes of patients with lymphoma.
    Stevenson FK; Gregg EO; Smith JL; Stevenson GT
    Br J Cancer; 1984 Nov; 50(5):579-86. PubMed ID: 6333886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy.
    Stevenson FK; Glennie MJ; Johnston DM; Tutt AL; Stevenson GT
    Br J Cancer; 1984 Sep; 50(3):407-13. PubMed ID: 6380556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
    Qian GX; Fu SM; Solanki DL; Rai KR
    J Immunol; 1984 Dec; 133(6):3396-400. PubMed ID: 6333459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential expression of IgG1 antibodies specific for L2C leukaemia IgM idiotypic determinants in tumour-protected strain 2 guinea-pigs.
    Ricardo MJ; Grimm DT
    Immunology; 1983 Apr; 48(4):763-9. PubMed ID: 6187671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
    Tamura GS; McGrath MS; Weissman IL
    J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal rheumatoid factor-secreting cells in a patient with mixed cryoglobulinemia. Homogeneity and stability of the idiotypic production and in vitro idiotypic suppression.
    Pasquali JL; Martin T; Knapp AM; Levallois H; Farradji A
    J Immunol; 1989 Sep; 143(6):1826-31. PubMed ID: 2789250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
    King CA; Wills MR; Hamblin TJ; Stevenson FK
    Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody.
    Krolick KA; Isakson PC; Uhr JW; Vitetta ES
    J Immunol; 1979 Nov; 123(5):1928-35. PubMed ID: 385772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for idiotypic sharing between conventional and naturally activated B cells.
    Song CH; Calandra GB; Miller A; Sercarz EE; Keller MA
    Eur J Immunol; 1991 Sep; 21(9):2005-10. PubMed ID: 1889454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo generation and function of B cells in the presence of a monoclonal anti-IgM antibody: implications for B cell tolerance.
    Gause A; Yoshida N; Kappen C; Rajewsky K
    Eur J Immunol; 1987 Jul; 17(7):981-90. PubMed ID: 3497044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of BCL1 cells by polyclonal activators and inhibition of growth and IgM secretion by anti-IgM.
    Severinson E; Torres A; Möller G
    Scand J Immunol; 1983 Aug; 18(2):153-62. PubMed ID: 6192491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
    Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
    Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular idiotypic immunoglobulin arising from human leukemic B lymphocytes.
    Stevenson FK; Hamblin TJ; Stevenson GT; Tutt AL
    J Exp Med; 1980 Dec; 152(6):1484-96. PubMed ID: 6969771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM.
    Perek Y; Hurwitz E; Burowski D; Haimovich J
    J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.